Rtw Investments, LP’s Fulcrum Therapeutics Inc Position
Does Rtw Investments, LP own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 5.85M shares worth $36M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$36M
Q2 2024
Shares
5.85M
% of Portfolio
+0.56%
Quarters Held
16
position exited
Position History FULC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 5.85M | $36M | +0.56% |
| Q1 2024 | 5.85M | $55M | +0.81% |
| Q4 2023 | 5.47M | $37M | +0.58% |
| Q3 2023 | 5.82M | $26M | +0.55% |
| Q2 2023 | 6.06M | $20M | +0.38% |
| Q1 2023 | 5.51M | $16M | +0.33% |
| Q4 2022 | 4.99M | $36M | +0.74% |
| Q3 2022 | 3.99M | $32M | +0.74% |
| Q2 2022 | 3.96M | $19M | +0.50% |
| Q1 2022 | 3.61M | $85M | +1.77% |
| Q4 2021 | 3.87M | $68M | +1.00% |
| Q3 2021 | 3.86M | $109M | +1.64% |
| Q2 2021 | 3.21M | $34M | +0.51% |
| Q1 2021 | 3.21M | $38M | +0.59% |
| Q4 2020 | 2.07M | $24M | +0.41% |
| Q3 2020 | 1.15M | $9M | +0.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of FULC.